Linguistic adaptation into Spanish and validation of the Arthritis Treatment Satisfaction Questionnaire;Adaptación al castellano y validación del cuestionario Arthritis Treatment Satisfaction Questionnaire

Medicina Clinica

Volumn 125, Issue 3, 2005, Pages 84-92

  Ruiz, Miguel ^a   Campillo, Miguel A ^b   Monfort, Jordi ^b   Pardo, Antonio ^a   Rejas, Javier ^c   Soto, Javier ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c PFIZER INC   (United States)

Author keywords

ARTS; Linguistic adaptation; Osteoarthritis; Spanish; Treatment satisfaction; Validation

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADAPTATION; ADULT; AGED; ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; FOLLOW UP; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; LINGUISTICS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PSYCHOMETRY; QUESTIONNAIRE; SELF REPORT; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 22944445160     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076736     Document Type: Article

References (38)

1. Blixen CE, Kippes C. Depression, social support, and quality of life in older adults with osteoarthritis. Image J Nurs Sch. 1999;31:221-6.
2. de Bock, Kaptein AA, Touw-Otten F, Mulder JD. Health-related quality of life in patients with osteoarthritis in a family practice setting. Arthritis Care Res. 1995;8:88-93.
3. Espallargues M, Alonso J, Ruigómez A, Antó JM. Los trastornos osteoarticulares en los ancianos: una aproximación a su impacto poblacional. Med Clin (Barc). 1996;106:601-6.
4. American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum. 2000;43:1905-15.
5. Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum. 2000;43:1478-87.
6. Manek NJ, Lane NE. Osteoarthritis: current concepts in diagnosis and management. Am Fam Physician. 2000;61:1795-804.
7. Russell RI. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy. Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S14-8.
8. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114:257-63.
9. Smalley WE, Griffin MR. The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am. 1996;25:373-96.
10. Davies NM, McLachlan AJ, Day RO, Williams KM. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet. 2000;38:225-42.
11. Rose MJ, Woolf EJ, Matuszewski BK. Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection. J Chromatogr Biomed Sci Appl. 2000;738:377-85.
12. Paulson SK, Hribar JD, Liu NW, Hajdu E, Bible RH Jr, Piergies A, et al. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers. Drug Metab Dispos. 2000;28:308-14.
13. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA. 1999;96:272-7.
14. Herdman M. Medida de la calidad de vida relacionada con la salud. Med Clin (Barc). 2000;114 Suppl 3:S22-S5.
15. Ruiz MA, Rejas J. Calidad de vida y otras medidas de salud informadas por el paciente. En: Domínguez-Gil A, Soto J, editores. Farmacoeconomía e investigación de resultados en la salud: principios y práctica. Situación actual y perspectivas futuras en España. Madrid: Fundación José Casares Gil; 2000. p. 115-59.
16. Fitzpatrick F, Badley EM. Outcomes in rheumatology. An overview of disability. Br J Rheumatol. 1996;35:184-7.
17. Carr AJ, Thompson PW, Kirwan JR. Quality of life measures. Br J Rheumatol. 1996;35:275-81.
18. Wolfe F. The epidemiology of drug treatment failure in rheumatoid arthritis. Baillieres Clin Rheumatol. 1995;9:619-32.
19. Trudeau E, Pouchot J, Hellot SC, Goguel J. Psychometric validation of the Arthritis Treatment Satisfaction (ARTS) questionnaire. Value in Health. 2001;4 (resumen PA010).
20. O'Connor R. Issues in the measurement of health-related quality of life. Melbourne, Australia: NHMRC National Center for Health Program Evaluation; 1993.
21. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N, for the European Regulatory Issues on Quality of Life Assessment Group. Patient-reported outcomes: the example of health-related quality of life - A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal. 2002;36:209-38.
22. a ed. México: McGraw-Hill; 1995.
23. Fayers PM, Machin D. Quality of life. Assessment, analysis and interpretation. Chichester: Wiley; 2000.
24. Rummel RJ. Applied factor analysis. Evanston: Northwestern University Press; 1970.
25. Cattel RB. Factor analysis. An introduction and manual for the psychologist and social scientist. New York: Harper and Row; 1952.
26. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
27. Alonso J, Prieto L, Antó JM. Versión española del SF-36 Health Survey (Cuestionario de Salud SF-36): un instrumento para la medida de resultados clínicos. Med Clin (Barc). 1995;104:771-6.
28. López-García E, Banegas JR, Graciani A, Gutiérrez-Fisac JL, Alonso J, Rodríguez-Artalejo FC. Valores de referencia de la versión española del cuestionario de Salud SF-36 en población adulta de más de 60 años. Med Clin (Barc). 2003;120:568-73.
29. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
30. Val A, Amorós G, Martínez P, Fernández ML, León M. Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del test de Morisky y Green. Aten Primaria. 1992;10:767-70.
31. Rovinelli RJ, Hambleton RK. On the use of content specialists in the assessment of criterion-referenced test item validity. Dutch J Educ Research. 1977;2:49-60.
32. Sinha SP, Nayyar P, Sinha SP. Social support and self-control as variables in attitude toward life and perceived control among older people in India. J Soc Psychol. 2002;142:527-40.
33. Dedhiya S, Kong SX. Quality of life: an overview of the concept and measures. Pharm World Sci. 1995;17:141-8.
34. Althof SE, Corty E, Levine SB, Levine F, Burnett AL, McVary KV, et al. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999;53:793-9.
35. Bradley C. Diabetes Treatment Satisfaction Questionnaire (DTSQ). En: Bradley C, editor. Handbook of Psychology and Diabetes. Amsterdam: Harwood Academic Publishers; 1994. p. 111-32.
36. Kane RL, Maciejewski M, Finch M. The relationship of patient satisfaction with care and clinical outcomes. Med Care. 1997;35:714-30.
37. Aharony L, Strasser S. Patient satisfaction: what we know about and what we still need to explore. Medical Care Review. 1993;50:49-79.
38. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M. Issues in the measurement of satisfaction with treatment. The Am J of Managed Care. 1997;3:579-94.